An Oncology Fellow is a physician undergoing advanced training after completing medical residency, specializing in the complex field of cancer care. This fellowship typically spans two to three years and focuses on developing expertise in diagnosing and managing various types of cancer. Fellows gain hands-on experience in outpatient clinics, inpatient wards, and infusion centers, learning to administer chemotherapy, immunotherapy, and other targeted treatments. They work alongside multidisciplinary teams, including surgeons, radiation oncologists, and pathologists, to provide comprehensive care tailored to each patient’s unique cancer type and stage. The fellowship also emphasizes understanding cancer biology, molecular diagnostics, and emerging therapies to stay at the forefront of oncology advancements.
Beyond clinical practice, Oncology Fellows actively participate in research to improve cancer treatments and outcomes. They often engage in clinical trials, translational research, and data analysis, contributing to scientific knowledge that shapes future standards of care. Communication skills are critical during this period, as fellows support patients through difficult diagnoses, treatment side effects, and palliative care discussions. Successfully completing an oncology fellowship prepares physicians to become board-certified oncologists capable of leading cancer care teams, advancing research, and delivering compassionate, evidence-based treatment to improve survival and quality of life for cancer patients. This rigorous training ultimately shapes the next generation of leaders in oncology.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China